Yogesh A. Sabnis, Ph.D. - Publications

2002 The University of Mississippi, USA 
Pharmaceutical Chemistry

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Liu Q, Sabnis Y, Zhao Z, Zhang T, Buhrlage SJ, Jones LH, Gray NS. Developing irreversible inhibitors of the protein kinase cysteinome. Chemistry & Biology. 20: 146-59. PMID 23438744 DOI: 10.1016/j.chembiol.2012.12.006  0.44
2008 Muthas D, Sabnis YA, Lundborg M, Karlén A. Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering. Journal of Molecular Graphics & Modelling. 26: 1237-51. PMID 18203638 DOI: 10.1016/j.jmgm.2007.11.005  0.44
2007 Rönn R, Gossas T, Sabnis YA, Daoud H, Kerblom E, Danielson UH, Sandström A. Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry. 15: 4057-68. PMID 17449253 DOI: 10.1016/j.bmc.2007.03.089  0.44
2007 Ortqvist P, Peterson SD, Kerblom E, Gossas T, Sabnis YA, Fransson R, Lindeberg G, Helena Danielson U, Karlén A, Sandström A. Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry. 15: 1448-74. PMID 17113777 DOI: 10.1016/j.bmc.2006.11.003  0.44
2006 Wannberg J, Sabnis YA, Vrang L, Samuelsson B, Karlén A, Hallberg A, Larhed M. A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chains. Bioorganic & Medicinal Chemistry. 14: 5303-15. PMID 16621572 DOI: 10.1016/j.bmc.2006.03.045  0.44
2006 Rönn R, Sabnis YA, Gossas T, Akerblom E, Danielson UH, Hallberg A, Johansson A. Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3. Bioorganic & Medicinal Chemistry. 14: 544-59. PMID 16213143 DOI: 10.1016/j.bmc.2005.08.045  0.44
2005 Muthas D, Nöteberg D, Sabnis YA, Hamelink E, Vrang L, Samuelsson B, Karlén A, Hallberg A. Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II. Bioorganic & Medicinal Chemistry. 13: 5371-90. PMID 16054370 DOI: 10.1016/j.bmc.2005.06.048  0.44
2004 Desai PV, Patny A, Sabnis Y, Tekwani B, Gut J, Rosenthal P, Srivastava A, Avery M. Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. Journal of Medicinal Chemistry. 47: 6609-15. PMID 15588096 DOI: 10.1021/jm0493717  0.44
2003 Batra S, Sabnis YA, Rosenthal PJ, Avery MA. Structure-based approach to falcipain-2 inhibitors: synthesis and biological evaluation of 1,6,7-trisubstituted dihydroisoquinolines and isoquinolines. Bioorganic & Medicinal Chemistry. 11: 2293-9. PMID 12713840 DOI: 10.1016/S0968-0896(03)00117-2  0.44
2003 Sabnis YA, Desai PV, Rosenthal PJ, Avery MA. Probing the structure of falcipain-3, a cysteine protease from Plasmodium falciparum: comparative protein modeling and docking studies. Protein Science : a Publication of the Protein Society. 12: 501-9. PMID 12592020 DOI: 10.1110/ps.0228103  0.44
2003 Illapakurthy AC, Sabnis YA, Avery BA, Avery MA, Wyandt CM. Interaction of artemisinin and its related compounds with hydroxypropyl-beta-cyclodextrin in solution state: experimental and molecular-modeling studies. Journal of Pharmaceutical Sciences. 92: 649-55. PMID 12587126 DOI: 10.1002/jps.10319  0.44
2002 Sabnis Y, Rosenthal PJ, Desai P, Avery MA. Homology modeling of falcipain-2: validation, de novo ligand design and synthesis of novel inhibitors. Journal of Biomolecular Structure & Dynamics. 19: 765-74. PMID 11922834 DOI: 10.1080/07391102.2002.10506783  0.44
2002 Avery MA, Alvim-Gaston M, Rodrigues CR, Barreiro EJ, Cohen FE, Sabnis YA, Woolfrey JR. Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies. Journal of Medicinal Chemistry. 45: 292-303. PMID 11784134 DOI: 10.1021/jm0100234  0.44
2002 El Sayed KA, Orabi KY, Dunbar DC, Hamann MT, Avery MA, Sabnis YA, Mossa JS, El-Feraly FS. Transformation of lactone to lactam in sarcophine and antimalarial activity of the resulting N-substituted azasarcophines Tetrahedron. 58: 3699-3708. DOI: 10.1016/S0040-4020(02)00330-7  0.44
Show low-probability matches.